Skip to main content
Log in

Supplement intervention associated with nutritional deficiencies in autism spectrum disorders: a systematic review

  • Original Contribution
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Abstract

Purpose

Nutritional supplements have been used for correction of deficiencies that may occur in patient with autism spectrum disorder (ASD) and to improve core symptoms. We aim to provide current best evidence about supplements for nutritional deficiencies and core symptoms in children with ASD and to evaluate the effectiveness and safety.

Methods

A systematic literature search of scientific databases was performed to retrieve relevant randomized controlled trials. Risk of bias was assessed for each study.

Results

18 randomized controlled trials of five supplements were included. B6/Mg was not helpful for improving ASD symptoms (seven RCTs). Two RCTs of methyl B12 reported some improvement in ASD severity but the effects on the correction of deficiencies were inconclusive. Two RCTs of vitamin D3 both reported increased levels of mean 25(OH)D in serum but inconsistent results in behavioral outcomes. Omega-3 fatty acid supplementation did not affect ASD behaviors but may correct deficiencies (six RCTs). One RCT of folinic acid reported positive results in improving ASD symptoms measured by various behavioral scales.

Conclusions

Current evidence for the use of supplements for correcting nutritional deficiencies in children with ASD and to improve the symptoms is little. More studies are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub, Arlington, Virginia

  2. Nardone S, Elliott E (2016) The interaction between the immune system and epigenetics in the etiology of autism spectrum disorders. Front Neurosci. doi:10.3389/fnins.2016.00329

    Article  PubMed Central  PubMed  Google Scholar 

  3. Packer A (2016) Neocortical neurogenesis and the etiology of autism spectrum disorder. Neurosci Biobehav Rev 64:185–195

    Article  PubMed  Google Scholar 

  4. Dawson G, Rice CE (2016) The complex etiology of autism presents challenges in risk communication. Pediatrics 137(2):1–2

    Google Scholar 

  5. Bradshaw J, Koegel LK, Koegel RL (2017) Improving functional language and social motivation with a parent-mediated intervention for toddlers with autism spectrum disorder. J Autism Dev Disord. doi:10.1007/s10803-017-3155-8

    Article  PubMed  Google Scholar 

  6. Chang Y-C, Laugeson EA, Gantman A, Ellingsen R, Frankel F, Dillon AR (2014) Predicting treatment success in social skills training for adolescents with autism spectrum disorders: The UCLA Program for the Education and Enrichment of Relational Skills. Autism 18(4):467–470

    Article  PubMed  Google Scholar 

  7. Bishop-Fitzpatrick L, Minshew NJ, Eack SM (2014) A systematic review of psychosocial interventions for adults with autism spectrum disorders. In:Volkmar FR, Reichow B, McPartland JC (eds) Adolescents and adults with autism spectrum disorders. Springer, New York, pp 315–327

    Chapter  Google Scholar 

  8. McPheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN, Veenstra-VanderWeele J (2011) A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics 127(5):e1312–e1321

    Article  PubMed  Google Scholar 

  9. Fung LK, Mahajan R, Nozzolillo A, Bernal P, Krasner A, Jo B, Coury D, Whitaker A, Veenstra-Vanderweele J, Hardan AY (2016) Pharmacologic treatment of severe irritability and problem behaviors in autism: a systematic review and meta-analysis. Pediatrics 137(Supplement 2):S124–S135

    Article  PubMed  Google Scholar 

  10. Benevides TW, Carretta HJ, Mandell DS (2016) Differences in perceived need for medical, therapeutic, and family support services among children with ASD. Pediatrics 137(Supplement 2):S176–S185

    Article  PubMed  Google Scholar 

  11. Jia F, Wang B, Shan L, Xu Z, Staal WG, Du L (2015) Core symptoms of autism improved after vitamin D supplementation. Pediatrics 135(1):e196–e198

    Article  PubMed  Google Scholar 

  12. Cannell JJ (2017) Vitamin D and autism, what’s new? Rev Endocr Metab Disord 18(2):183–193

    Article  CAS  PubMed  Google Scholar 

  13. Zhang Y, Hodgson NW, Trivedi MS, Abdolmaleky HM, Fournier M, Cuenod M, Do KQ, Deth RC (2016) Decreased brain levels of vitamin B12 in aging, autism and schizophrenia. PLoS One 11(1):e0146797

    Article  PubMed  PubMed Central  Google Scholar 

  14. Ranjan S, Nasser JA (2015) Nutritional status of individuals with autism spectrum disorders: do we know enough? Adv Nutr Int Rev J 6(4):397–407

    Article  Google Scholar 

  15. Vancassel S, Durand G, Barthelemy C, Lejeune B, Martineau J, Guilloteau D, Andres C, Chalon S (2001) Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids (PLEFA) 65(1):1–7

    Article  CAS  Google Scholar 

  16. Wiest M, German JB, Harvey DJ, Watkins S, Hertz-Picciotto I (2009) Plasma fatty acid profiles in autism: a case-control study. Prostaglandins Leukot Essent Fatty Acids 80(4):221–227

    Article  CAS  PubMed  Google Scholar 

  17. Al-Farsi YM, Waly MI, Deth RC, Al-Sharbati MM, Al-Shafaee M, Al-Farsi O, Al-Khaduri MM, Gupta I, Ali A, Al-Khalili M (2013) Low folate and vitamin B12 nourishment is common in Omani children with newly diagnosed autism. Nutrition 29(3):537–541

    Article  CAS  PubMed  Google Scholar 

  18. Karin I, Borggraefe I, Catarino CB, Kuhm C, Hoertnagel K, Biskup S, Opladen T, Blau N, Heinen F, Klopstock T (2017) Folinic acid therapy in cerebral folate deficiency: marked improvement in an adult patient. J Neurol. doi:10.1007/s00415-016-8387-6

    Article  PubMed  Google Scholar 

  19. Gogou M, Kolios G (2017) The effect of dietary supplements on clinical aspects of autism spectrum disorder: a systematic review of the literature. Brain Dev. doi:10.1016/j.braindev.2017.03.029

    Article  PubMed  Google Scholar 

  20. Taylor JL, Dove D, Veenstra-VanderWeele J, Sathe NA, McPheeters ML, Jerome RN, Warren Z (2012) Interventions for adolescents and young adults with autism spectrum disorders. AHRQ Publication, Rockville

    Google Scholar 

  21. Weitlauf AS, Sathe N, McPheeters ML, Warren ZE (2017) Interventions targeting sensory challenges in autism spectrum disorder: a systematic review. Pediatrics 139(6):e20170347

    Article  PubMed  Google Scholar 

  22. Findling RL, Maxwell K, Scotese-Wojtila L, Huang J, Yamashita T, Wiznitzer M (1997) High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study. J Autism Dev Disord 27(4):467–478

    Article  CAS  PubMed  Google Scholar 

  23. Lelord G, Muh J, Barthelemy C, Martineau J, Garreau B, Callaway E (1981) Effects of pyridoxine and magnesium on autistic symptoms—initial observations. J Autism Dev Disord 11(2):219–230

    Article  CAS  PubMed  Google Scholar 

  24. Martineau J, Barthelemy C, Garreau B, Lelord G (1985) Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism. Biol Psychiatry 20(5):467–478

    Article  CAS  PubMed  Google Scholar 

  25. Tolbert L, Haigler T, Waits MM, Dennis T (1993) Brief report: lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium. J Autism Dev Disord 23(1):193–199

    Article  CAS  PubMed  Google Scholar 

  26. Bertoglio K, Jill James S, Deprey L, Brule N, Hendren RL (2010) Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism. J Altern Complement Med 16(5):555–560

    Article  PubMed  Google Scholar 

  27. Hendren RL, James SJ, Widjaja F, Lawton B, Rosenblatt A, Bent S (2016) Randomized, placebo-controlled trial of methyl B12 for children with autism. J Child Adolesc Psychopharmacol 26(9):774–783

    Article  CAS  PubMed  Google Scholar 

  28. Saad K, Abdel‐Rahman AA, Elserogy YM, Al‐Atram AA, El‐Houfey AA, Othman HA, Bjørklund G, Jia F, Urbina MA, Abo‐Elela MGM (2016) Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder. J Child Psychol Psychiatry. doi:10.1111/jcpp.12652

    Article  PubMed  Google Scholar 

  29. Kerley CP, Power C, Gallagher L, Coghlan D (2017) Lack of effect of vitamin D 3 supplementation in autism: a 20-week, placebo-controlled RCT. Arch Dis Child. doi:10.1136/archdischild-2017-312783

    Article  PubMed  Google Scholar 

  30. Amminger GP, Berger GE, Schäfer MR, Klier C, Friedrich MH, Feucht M (2007) Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry 61(4):551–553

    Article  CAS  PubMed  Google Scholar 

  31. Bent S, Bertoglio K, Ashwood P, Bostrom A, Hendren RL (2011) A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord 41(5):545–554

    Article  PubMed  Google Scholar 

  32. Bent S, Hendren RL, Zandi T, Law K, Choi J-E, Widjaja F, Kalb L, Nestle J, Law P (2014) Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism. J Am Acad Child Adolesc Psychiatry 53(6):658–666

    Article  PubMed  PubMed Central  Google Scholar 

  33. Mankad D, Dupuis A, Smile S, Roberts W, Brian J, Lui T, Genore L, Zaghloul D, Iaboni A, Marcon PMA (2015) A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism. Mol Autism. doi:10.1186/s13229-015-0010-7

    Article  PubMed Central  PubMed  Google Scholar 

  34. Voigt RG, Mellon MW, Katusic SK, Weaver AL, Matern D, Mellon B, Jensen CL, Barbaresi WJ (2014) Dietary docosahexaenoic acid supplementation in children with autism. J Pediatr Gastroenterol Nutr 58(6):715–722

    CAS  PubMed  Google Scholar 

  35. Yui K, Koshiba M, Nakamura S, Kobayashi Y (2012) Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: a double-blind, placebo-controlled, randomized trial. J Clin Psychopharmacol 32(2):200–206

    Article  CAS  PubMed  Google Scholar 

  36. Frye R, Slattery J, Delhey L, Furgerson B, Strickland T, Tippett M, Sailey A, Wynne R, Rose S, Melnyk S (2016) Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol Psychiatry. doi:10.1038/mp.2016.168

    Article  PubMed  PubMed Central  Google Scholar 

  37. Dosman CF, Brian JA, Drmic IE, Senthilselvan A, Harford MM, Smith RW, Sharieff W, Zlotkin SH, Moldofsky H, Roberts SW (2007) Children with autism: effect of iron supplementation on sleep and ferritin. Pediatr Neurol 36(3):152–158

    Article  PubMed  Google Scholar 

  38. Sun C, Zou M, Zhao D, Xia W, Wu L (2016) Efficacy of folic acid supplementation in autistic children participating in structured teaching: an open-label trial. Nutrients 8(6):337

    Article  PubMed Central  Google Scholar 

  39. Gabriele S, Sacco R, Persico AM (2014) Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis. Eur Neuropsychopharmacol 24(6):919–929

    Article  CAS  PubMed  Google Scholar 

  40. Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, Tsuchiya KJ, Sugihara G, Iwata Y, Suzuki K (2010) Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry 67(1):59–68

    Article  CAS  PubMed  Google Scholar 

  41. Berger A, Schaumburg H (1984) More on neuropathy from pyridoxine abuse. N Engl J Med 311(15):986–987

    CAS  PubMed  Google Scholar 

  42. Fine KD, Santa Ana CA, Fordtran JS (1991) Diagnosis of magnesium-induced diarrhea. N Engl J Med 324(15):1012–1017

    Article  CAS  PubMed  Google Scholar 

  43. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80(6):1611–1617

    Article  CAS  PubMed  Google Scholar 

  44. James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, Hubanks A, Gaylor DW (2009) Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr 89(1):425–430

    Article  CAS  PubMed  Google Scholar 

  45. Kalinina E, Chernov N, Novichkova M (2014) Role of glutathione, glutathione transferase, and glutaredoxin in regulation of redox-dependent processes. Biochemistry (Moscow) 79(13):1562–1583

    Article  CAS  Google Scholar 

  46. Wang T, Shan L, Du L, Feng J, Xu Z, Staal WG, Jia F (2016) Serum concentration of 25-hydroxyvitamin D in autism spectrum disorder: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry 25(4):341–350

    Article  PubMed  Google Scholar 

  47. Fernell E, Bejerot S, Westerlund J, Miniscalco C, Simila H, Eyles D, Gillberg C, Humble MB (2015) Autism spectrum disorder and low vitamin D at birth: a sibling control study. Mol Autism. doi:10.1186/2040-2392-6-3

    Article  PubMed Central  PubMed  Google Scholar 

  48. Cannell JJ, Grant WB (2013) What is the role of vitamin D in autism? Dermato-endocrinology 5(1):199–204

    Article  PubMed  PubMed Central  Google Scholar 

  49. Huang Y-N, Ho Y-J, Lai C-C, Chiu C-T, Wang J-Y (2015) 1,25-Dihydroxyvitamin D3 attenuates endotoxin-induced production of inflammatory mediators by inhibiting MAPK activation in primary cortical neuron-glia cultures. J Neuroinflamm 12(1):147

    Article  CAS  Google Scholar 

  50. Patrick RP, Ames BN (2014) Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. FASEB J 28(6):2398–2413

    Article  CAS  PubMed  Google Scholar 

  51. Castro K, Klein LdS, Baronio D, Gottfried C, Riesgo R, Perry IS (2016) Folic acid and autism: what do we know? Nutr Neurosci 19(7):310–317

    Article  CAS  PubMed  Google Scholar 

  52. Delmelle F, Thöny B, Clapuyt P, Blau N, Nassogne M-C (2016) Neurological improvement following intravenous high-dose folinic acid for cerebral folate transporter deficiency caused by FOLR-1 mutation. Eur J Paediatr Neurol 20(5):709–713

    Article  PubMed  Google Scholar 

  53. Yehuda S, Rabinovitz S, Mostofsky D (2005) Essential fatty acids and the brain: from infancy to aging. Neurobiol Aging 26(1):98–102

    Article  PubMed  Google Scholar 

  54. Mazahery H, Stonehouse W, Delshad M, Kruger MC, Conlon CA, Beck KL, von Hurst PR (2017) Relationship between long chain n-3 polyunsaturated fatty acids and autism spectrum disorder: systematic review and meta-analysis of case–control and randomised controlled trials. Nutrients 9(2):155

    Article  PubMed Central  Google Scholar 

  55. Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, Van der Oord S, Döpfner M (2013) Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 170(3):275–289

    Article  PubMed  Google Scholar 

  56. Chen AT, Chibnall JT, Nasrallah HA (2016) A meta-analysis of placebo-controlled trials of omega-3 fatty acid augmentation in schizophrenia: possible stage-specific effects. Ann Clin Psychiatry 27(4):289–296

    Google Scholar 

  57. Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, Drago F, Caraci F (2014) Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One 9(5):e96905

    Article  PubMed  PubMed Central  Google Scholar 

  58. James SJ, Melnyk S, Jernigan S, Hubanks A, Rose S, Gaylor DW (2008) Abnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autism. J Autism Dev Disord 38(10):1966–1975

    Article  PubMed  PubMed Central  Google Scholar 

  59. Horvath A, Łukasik J, Szajewska H (2017) ω-3 Fatty acid supplementation does not affect autism spectrum disorder in children: a systematic review and meta-analysis. J Nutr. doi:10.3945/jn.116.242354

    Article  PubMed  Google Scholar 

  60. Heinrichs SC (2010) Dietary ω-3 fatty acid supplementation for optimizing neuronal structure and function. Mol Nutr Food Res 54(4):447–456

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

No funding was received in support of this work.

Author information

Authors and Affiliations

Authors

Contributions

Y-JL and D-XX defined the focus of the review. All authors searched and screened the papers for inclusion. Y-JL summarized included papers. All authors contributed to quality assessment of included papers. Y-JL drafted the manuscript. All authors contributed to reviewing the manuscript and read and approved the submitted version.

Corresponding author

Correspondence to Da-Xiong Xiang.

Ethics declarations

Conflict of interest

The authors have no relevant interests to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, YJ., Li, YM. & Xiang, DX. Supplement intervention associated with nutritional deficiencies in autism spectrum disorders: a systematic review. Eur J Nutr 57, 2571–2582 (2018). https://doi.org/10.1007/s00394-017-1528-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-017-1528-6

Keywords

Navigation